Hsiao-Hui Lin
Obstetrics & Gynecology · Baltimore, MDNPI 1548254246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 30.0% of the total. Reporting peaked in 2023 at $820 and has fallen 97.0% since, to $24 in 2025.
Across 216 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$405
- Therapeuticsmd, Inc.$358
- Exeltis, USA Inc.$276
- Avion Pharmaceuticals$215
- Astellas Pharma US Inc$204
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,33794%
- Education$1986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 71 | $1,060 |
| Pfizer | 24 | $405 |
| Therapeuticsmd, Inc. | 25 | $358 |
| Exeltis, USA Inc. | 16 | $276 |
| Avion Pharmaceuticals | 16 | $215 |
| Astellas Pharma US Inc | 7 | $204 |
| Millicent US Inc | 8 | $134 |
| Myovant Sciences Inc. | 6 | $116 |
| Bayer | 5 | $81 |
| Amgen(2 entities) | 4 | $80 |
| AMAG Pharmaceuticals, Inc. | 4 | $71 |
| Mayne Pharma Commercial LLC | 4 | $70 |
| Evofem Biosciences, Inc. | 4 | $67 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Scynexis, Inc. | 2 | $53 |
| Duchesnay USA Incorporated | 2 | $39 |
| Agile Therapeutics, Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Organon | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $17 |
| Applied Medical Resources Corporation | 1 | $16 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,535 in reported general payments places this provider in the 85th percentile of 842 obstetrics & gynecology providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 28 | $2,305 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Baltimore
- Danielle ShillerBaltimore$221K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Christina EnzmannBaltimore$63K
- Latasha MurphyBaltimore$41K
- Ishrat RafiBaltimore$29K
- Colleen McCormickBaltimore$29K
- Jenell ColemanBaltimore$18K
- David MatthewsBaltimore$12K
- Anne BurkeBaltimore$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.